Try GOLD - Free
Faster drug trials in works as India eyes export gains
Mint Mumbai
|September 04, 2025
New drugs may reach chemists quicker and clinical trials kick off earlier, with the Union health ministry drafting rules to cut the time to process approvals by half and help India expand its footprint in the $1.55 billion global clinical trials industry.
The proposed changes will streamline the process for testing licences and certain studies by replacing the old licensing system with a faster online notification system, the health ministry said on Wednesday.
This will require an amendment to India's New Drugs and Clinical Trials Rules, 2019, potentially reducing the application processing time from 90 to 45 working days.
A key change proposed in the draft New Drugs and Clinical Trials (Amendment) Rules, 2025 allows firms to start studies on drugs meant for export with an online notification if the product's been approved in major markets such as the US, UK, EU, Japan, Australia and Canada.
These studies will be limited to a maximum of 48 healthy adult volunteers.
The ministry said the changes aim to reduce licence applications by about 50%.
The public has 30 days to submit comments.
This story is from the September 04, 2025 edition of Mint Mumbai.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Mumbai
Mint Mumbai
Dissent aside, Tata Trusts keen to keep Tata Sons private
Tata Trusts remains committed to its decision to keep Tata Sons private, two Tata executives told Mint, hours after the Shapoorji Pallonji Group issued a public statement seeking a public share sale of the Tata Group holding company.
2 mins
October 13, 2025
Mint Mumbai
What the govt's capex growth does not reveal
The government's capital expenditure has surged sharply in the first five months (April-August) of FY26. It has already spent nearly 39% of the annual outlay of 11.2 trillion, a 43% year-on-year jump.
2 mins
October 13, 2025
Mint Mumbai
US seeks inventory model for e-comm
Negotiators cite 'level playing field', move may raise competition
2 mins
October 13, 2025
Mint Mumbai
EQT scraps Zelestra India sale, to pump in $600 mn
For scraps
2 mins
October 13, 2025
Mint Mumbai
INSIDE NADELLA'S AI RESET AT MICROSOFT
Earlier this month, Microsoft promoted Judson Althoff, its longtime sales boss, to chief executive of its commercial business, consolidating sales, marketing and operations across its products. The move was designed gence.
3 mins
October 13, 2025
Mint Mumbai
H-IB fee hike Trump's second blow to gems & jewellery firms
Losing sparkle
2 mins
October 13, 2025
Mint Mumbai
Slow drive for e-trucks as local sourcing rule bites
E-truck manufacturers wary of ambitious indigenization due to concerns over tepid demand
2 mins
October 13, 2025
Mint Mumbai
YOGA, AYURVEDA—INDIA CAN LEAD THE WISDOM ECONOMY
I was watching a video of a meditation studio in Manhattan when it struck me yet again. Twenty people, mostly American professionals, sitting cross-legged on expensive mats, were following breathing techniques that our grandparents and ancestors practised every morning.
2 mins
October 13, 2025
Mint Mumbai
Existing investors pour in $40 million into Dezerv
Wealth management platform Dezerv has raised ₹350 crore (about $40 million) in a new funding round from its existing investors, the company's top executive told Mint.
1 mins
October 13, 2025
Mint Mumbai
THE RECIPE OF TRUMPING ODDS: THE RSS PLAYBOOK
I have been watching Rashtriya Swayamsevak Sangh (RSS), now in its 101st year, for more than 50 years. Today, when its swayamsevaks (volunteers) are in power in Delhi and 14 other state capitals, there’s a curiosity about the secret of its success.
3 mins
October 13, 2025
Listen
Translate
Change font size